nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP3A4—bone cancer	0.769	1	CbGaD
Bezafibrate—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00475	0.0363	CbGpPWpGaD
Bezafibrate—PPARG—periosteum—bone cancer	0.00453	0.181	CbGeAlD
Bezafibrate—PPARD—Nuclear Receptors—NR1I2—bone cancer	0.00434	0.0332	CbGpPWpGaD
Bezafibrate—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00379	0.029	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00362	0.0277	CbGpPWpGaD
Bezafibrate—PPARG—leg—bone cancer	0.00361	0.144	CbGeAlD
Bezafibrate—PPARG—forelimb—bone cancer	0.00358	0.143	CbGeAlD
Bezafibrate—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00355	0.0272	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—BCOR—bone cancer	0.00347	0.0265	CbGpPWpGaD
Bezafibrate—PPARD—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00343	0.0263	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptors—NR1I2—bone cancer	0.00331	0.0253	CbGpPWpGaD
Bezafibrate—PPARG—hindlimb—bone cancer	0.00322	0.129	CbGeAlD
Bezafibrate—PPARD—The citric acid (TCA) cycle and respiratory electron transport—NDUFA12—bone cancer	0.00301	0.0231	CbGpPWpGaD
Bezafibrate—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00277	0.0212	CbGpPWpGaD
Bezafibrate—PPARG—appendage—bone cancer	0.00276	0.11	CbGeAlD
Bezafibrate—PPARA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00262	0.02	CbGpPWpGaD
Bezafibrate—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00259	0.0198	CbGpPWpGaD
Bezafibrate—SLCO1B1—Irinotecan Pathway—CYP3A4—bone cancer	0.00243	0.0186	CbGpPWpGaD
Bezafibrate—PPARG—Nuclear Receptors—NR1I2—bone cancer	0.00237	0.0181	CbGpPWpGaD
Bezafibrate—CYP1A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00237	0.0181	CbGpPWpGaD
Bezafibrate—Serum creatinine increased—Cisplatin—bone cancer	0.00226	0.0323	CcSEcCtD
Bezafibrate—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00217	0.0166	CbGpPWpGaD
Bezafibrate—CYP1A1—Benzo(a)pyrene metabolism—CYP3A4—bone cancer	0.00216	0.0166	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00211	0.0162	CbGpPWpGaD
Bezafibrate—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00208	0.0159	CbGpPWpGaD
Bezafibrate—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00208	0.0159	CbGpPWpGaD
Bezafibrate—PPARG—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00187	0.0143	CbGpPWpGaD
Bezafibrate—PPARA—Estrogen Receptor Pathway—JUN—bone cancer	0.00182	0.0139	CbGpPWpGaD
Bezafibrate—PPARA—Orphan transporters—TUBB4B—bone cancer	0.00181	0.0139	CbGpPWpGaD
Bezafibrate—Fenofibrate—CYP3A4—bone cancer	0.00178	0.309	CrCbGaD
Bezafibrate—PPARD—Generic Transcription Pathway—ZNF77—bone cancer	0.00175	0.0134	CbGpPWpGaD
Bezafibrate—Infection—Carboplatin—bone cancer	0.00168	0.024	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00166	0.0127	CbGpPWpGaD
Bezafibrate—PPARA—PPAR Alpha Pathway—CDK4—bone cancer	0.00162	0.0124	CbGpPWpGaD
Bezafibrate—PPARA—Orphan transporters—TUBB2A—bone cancer	0.00157	0.012	CbGpPWpGaD
Bezafibrate—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00151	0.0116	CbGpPWpGaD
Bezafibrate—Balsalazide—PTGS2—bone cancer	0.00148	0.258	CrCbGaD
Bezafibrate—Myositis—Epirubicin—bone cancer	0.00145	0.0208	CcSEcCtD
Bezafibrate—Pain—Carboplatin—bone cancer	0.00144	0.0207	CcSEcCtD
Bezafibrate—PPARA—connective tissue—bone cancer	0.00143	0.0573	CbGeAlD
Bezafibrate—CYP1A1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00137	0.0104	CbGpPWpGaD
Bezafibrate—Myositis—Doxorubicin—bone cancer	0.00134	0.0193	CcSEcCtD
Bezafibrate—PPARA—Generic Transcription Pathway—ZNF77—bone cancer	0.00133	0.0102	CbGpPWpGaD
Bezafibrate—CYP1A1—Estrogen metabolism—CYP3A4—bone cancer	0.00124	0.00951	CbGpPWpGaD
Bezafibrate—Clofibrate—CYP3A4—bone cancer	0.00124	0.214	CrCbGaD
Bezafibrate—PPARG—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00119	0.00911	CbGpPWpGaD
Bezafibrate—Transaminases increased—Epirubicin—bone cancer	0.00117	0.0168	CcSEcCtD
Bezafibrate—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00117	0.00891	CbGpPWpGaD
Bezafibrate—Serum creatinine increased—Epirubicin—bone cancer	0.00116	0.0166	CcSEcCtD
Bezafibrate—PPARD—tendon—bone cancer	0.00116	0.0462	CbGeAlD
Bezafibrate—CYP1A1—Xenobiotics—CYP3A4—bone cancer	0.00114	0.00874	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.00111	0.00851	CbGpPWpGaD
Bezafibrate—CYP1A1—Tamoxifen metabolism—CYP3A4—bone cancer	0.0011	0.00841	CbGpPWpGaD
Bezafibrate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0011	0.00839	CbGpPWpGaD
Bezafibrate—Renal failure acute—Cisplatin—bone cancer	0.00109	0.0156	CcSEcCtD
Bezafibrate—Transaminases increased—Doxorubicin—bone cancer	0.00108	0.0155	CcSEcCtD
Bezafibrate—Serum creatinine increased—Doxorubicin—bone cancer	0.00107	0.0154	CcSEcCtD
Bezafibrate—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.00105	0.00801	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP4V2—bone cancer	0.00102	0.0078	CbGpPWpGaD
Bezafibrate—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.00101	0.00771	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ZNF77—bone cancer	0.000956	0.00732	CbGpPWpGaD
Bezafibrate—HMGCR—connective tissue—bone cancer	0.000955	0.0382	CbGeAlD
Bezafibrate—Blood creatinine increased—Cisplatin—bone cancer	0.000944	0.0135	CcSEcCtD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000934	0.00715	CbGpPWpGaD
Bezafibrate—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000907	0.013	CcSEcCtD
Bezafibrate—Cramp muscle—Cisplatin—bone cancer	0.000907	0.013	CcSEcCtD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—JUN—bone cancer	0.00087	0.00666	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ZNF77—bone cancer	0.000843	0.00645	CbGpPWpGaD
Bezafibrate—Pancytopenia—Cisplatin—bone cancer	0.000827	0.0118	CcSEcCtD
Bezafibrate—PPARG—connective tissue—bone cancer	0.000789	0.0315	CbGeAlD
Bezafibrate—Acute coronary syndrome—Cisplatin—bone cancer	0.000765	0.011	CcSEcCtD
Bezafibrate—Myocardial infarction—Cisplatin—bone cancer	0.000761	0.0109	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—PLAU—bone cancer	0.000755	0.00578	CbGpPWpGaD
Bezafibrate—PPARD—NRF2 pathway—GSTP1—bone cancer	0.000739	0.00566	CbGpPWpGaD
Bezafibrate—PPARD—NRF2 pathway—TGFBR2—bone cancer	0.000739	0.00566	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000719	0.0055	CbGpPWpGaD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—bone cancer	0.000713	0.0102	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000691	0.00529	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.00069	0.00528	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Cisplatin—bone cancer	0.000688	0.00985	CcSEcCtD
Bezafibrate—Urethral disorder—Cisplatin—bone cancer	0.000683	0.00978	CcSEcCtD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.000681	0.00521	CbGpPWpGaD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.00066	0.00944	CcSEcCtD
Bezafibrate—HMGCR—tendon—bone cancer	0.000656	0.0262	CbGeAlD
Bezafibrate—Indomethacin—PTGS2—bone cancer	0.000654	0.114	CrCbGaD
Bezafibrate—CYP1A1—Estrogen Receptor Pathway—JUN—bone cancer	0.000644	0.00493	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ZNF77—bone cancer	0.000642	0.00491	CbGpPWpGaD
Bezafibrate—HMGCR—bone marrow—bone cancer	0.000636	0.0254	CbGeAlD
Bezafibrate—HMGCR—spinal cord—bone cancer	0.000633	0.0253	CbGeAlD
Bezafibrate—Photosensitivity—Methotrexate—bone cancer	0.00063	0.00901	CcSEcCtD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00063	0.00482	CbGpPWpGaD
Bezafibrate—Alopecia—Cisplatin—bone cancer	0.000616	0.00882	CcSEcCtD
Bezafibrate—Erythema—Cisplatin—bone cancer	0.000607	0.00869	CcSEcCtD
Bezafibrate—Glyburide—CYP3A4—bone cancer	0.000604	0.105	CrCbGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.0006	0.00459	CbGpPWpGaD
Bezafibrate—Renal failure acute—Methotrexate—bone cancer	0.000599	0.00857	CcSEcCtD
Bezafibrate—Flatulence—Cisplatin—bone cancer	0.000598	0.00856	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000595	0.00852	CcSEcCtD
Bezafibrate—PPARD—Generic Transcription Pathway—NR1I2—bone cancer	0.000593	0.00454	CbGpPWpGaD
Bezafibrate—Photosensitivity—Epirubicin—bone cancer	0.000589	0.00844	CcSEcCtD
Bezafibrate—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000587	0.00449	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000586	0.00448	CbGpPWpGaD
Bezafibrate—Muscle spasms—Cisplatin—bone cancer	0.000583	0.00835	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—bone cancer	0.000578	0.00828	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—bone cancer	0.000576	0.00824	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—GNA11—bone cancer	0.000563	0.0043	CbGpPWpGaD
Bezafibrate—Anaemia—Cisplatin—bone cancer	0.000561	0.00803	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—bone cancer	0.00056	0.00802	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—EZH2—bone cancer	0.00056	0.00428	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CDK4—bone cancer	0.000552	0.00422	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—MET—bone cancer	0.000552	0.00422	CbGpPWpGaD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00055	0.00788	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—bone cancer	0.000545	0.00781	CcSEcCtD
Bezafibrate—PPARG—tendon—bone cancer	0.000542	0.0217	CbGeAlD
Bezafibrate—Purpura—Epirubicin—bone cancer	0.000537	0.00769	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—bone cancer	0.000535	0.00766	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—bone cancer	0.000533	0.00763	CcSEcCtD
Bezafibrate—PPARG—bone marrow—bone cancer	0.000525	0.021	CbGeAlD
Bezafibrate—Renal failure acute—Doxorubicin—bone cancer	0.000519	0.00742	CcSEcCtD
Bezafibrate—Myalgia—Cisplatin—bone cancer	0.000517	0.0074	CcSEcCtD
Bezafibrate—PPARD—Adipogenesis—RB1—bone cancer	0.000511	0.00391	CbGpPWpGaD
Bezafibrate—Liver function test abnormal—Methotrexate—bone cancer	0.000511	0.00731	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—bone cancer	0.000509	0.00729	CcSEcCtD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000501	0.00384	CbGpPWpGaD
Bezafibrate—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000498	0.00713	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—bone cancer	0.000497	0.00711	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bone cancer	0.000493	0.00377	CbGpPWpGaD
Bezafibrate—Infection—Cisplatin—bone cancer	0.000492	0.00704	CcSEcCtD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.000488	0.00373	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Cisplatin—bone cancer	0.000485	0.00694	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—bone cancer	0.000485	0.00694	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—RB1—bone cancer	0.00048	0.00367	CbGpPWpGaD
Bezafibrate—Liver function test abnormal—Epirubicin—bone cancer	0.000478	0.00684	CcSEcCtD
Bezafibrate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000474	0.00363	CbGpPWpGaD
Bezafibrate—Migraine—Doxorubicin—bone cancer	0.000471	0.00675	CcSEcCtD
Bezafibrate—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000468	0.00358	CbGpPWpGaD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000466	0.00667	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000466	0.00667	CcSEcCtD
Bezafibrate—PPARG—Gene Expression—ZNF77—bone cancer	0.00046	0.00352	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—JUN—bone cancer	0.00046	0.00352	CbGpPWpGaD
Bezafibrate—Gastritis—Epirubicin—bone cancer	0.000458	0.00656	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000456	0.00653	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—bone cancer	0.000456	0.00653	CcSEcCtD
Bezafibrate—PPARD—Metabolism—NDUFA12—bone cancer	0.000454	0.00348	CbGpPWpGaD
Bezafibrate—Pancytopenia—Methotrexate—bone cancer	0.000454	0.0065	CcSEcCtD
Bezafibrate—PPARA—Generic Transcription Pathway—NR1I2—bone cancer	0.000452	0.00346	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000451	0.00646	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—bone cancer	0.000449	0.00642	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—bone cancer	0.000447	0.0064	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000444	0.0034	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000443	0.00339	CbGpPWpGaD
Bezafibrate—Liver function test abnormal—Doxorubicin—bone cancer	0.000442	0.00633	CcSEcCtD
Bezafibrate—Erectile dysfunction—Methotrexate—bone cancer	0.00044	0.0063	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Methotrexate—bone cancer	0.000436	0.00624	CcSEcCtD
Bezafibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000435	0.00333	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000435	0.00332	CbGpPWpGaD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000431	0.00617	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000431	0.00617	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—bone cancer	0.00043	0.00616	CcSEcCtD
Bezafibrate—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000429	0.00328	CbGpPWpGaD
Bezafibrate—Pancytopenia—Epirubicin—bone cancer	0.000425	0.00608	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—bone cancer	0.000424	0.00607	CcSEcCtD
Bezafibrate—Pain—Cisplatin—bone cancer	0.000424	0.00606	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000422	0.00605	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—bone cancer	0.000422	0.00605	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000422	0.00605	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—bone cancer	0.000414	0.00592	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—FUS—bone cancer	0.000412	0.00315	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—MDM2—bone cancer	0.000409	0.00313	CbGpPWpGaD
Bezafibrate—Photosensitivity reaction—Epirubicin—bone cancer	0.000408	0.00584	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—GNA11—bone cancer	0.000403	0.00308	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—EZH2—bone cancer	0.000401	0.00307	CbGpPWpGaD
Bezafibrate—Bronchitis—Doxorubicin—bone cancer	0.000398	0.0057	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000395	0.00566	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—bone cancer	0.000393	0.00563	CcSEcCtD
Bezafibrate—PPARA—Adipogenesis—RB1—bone cancer	0.00039	0.00298	CbGpPWpGaD
Bezafibrate—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000385	0.00294	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000385	0.00294	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000382	0.00292	CbGpPWpGaD
Bezafibrate—Pharyngitis—Methotrexate—bone cancer	0.00038	0.00543	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—NDUFA12—bone cancer	0.000379	0.0029	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000378	0.00289	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Methotrexate—bone cancer	0.000378	0.00541	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—bone cancer	0.000378	0.00541	CcSEcCtD
Bezafibrate—PPARD—Metabolism—NT5C3A—bone cancer	0.000377	0.00288	CbGpPWpGaD
Bezafibrate—Urethral disorder—Methotrexate—bone cancer	0.000375	0.00537	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000366	0.00524	CcSEcCtD
Bezafibrate—Hypersensitivity—Cisplatin—bone cancer	0.000365	0.00522	CcSEcCtD
Bezafibrate—Erythema multiforme—Methotrexate—bone cancer	0.000362	0.00518	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—JUN—bone cancer	0.000356	0.00272	CbGpPWpGaD
Bezafibrate—Pharyngitis—Epirubicin—bone cancer	0.000355	0.00509	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—bone cancer	0.000354	0.00506	CcSEcCtD
Bezafibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000353	0.0027	CbGpPWpGaD
Bezafibrate—Urethral disorder—Epirubicin—bone cancer	0.000351	0.00502	CcSEcCtD
Bezafibrate—PPARA—Metabolism—NDUFA12—bone cancer	0.000346	0.00265	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—bone cancer	0.000346	0.00265	CbGpPWpGaD
Bezafibrate—Diarrhoea—Cisplatin—bone cancer	0.000339	0.00485	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—bone cancer	0.000338	0.00485	CcSEcCtD
Bezafibrate—Alopecia—Methotrexate—bone cancer	0.000338	0.00484	CcSEcCtD
Bezafibrate—Erythema—Methotrexate—bone cancer	0.000333	0.00477	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—bone cancer	0.000329	0.00471	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—bone cancer	0.000327	0.00468	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—bone cancer	0.000325	0.00465	CcSEcCtD
Bezafibrate—PPARG—Generic Transcription Pathway—NR1I2—bone cancer	0.000324	0.00248	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000322	0.00246	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000316	0.00242	CbGpPWpGaD
Bezafibrate—Alopecia—Epirubicin—bone cancer	0.000316	0.00453	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—CDK4—bone cancer	0.000316	0.00242	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—FUS—bone cancer	0.000314	0.0024	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NT5C3A—bone cancer	0.000314	0.0024	CbGpPWpGaD
Bezafibrate—Erythema multiforme—Doxorubicin—bone cancer	0.000313	0.00448	CcSEcCtD
Bezafibrate—Rash—Cisplatin—bone cancer	0.000312	0.00447	CcSEcCtD
Bezafibrate—Dermatitis—Cisplatin—bone cancer	0.000312	0.00447	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—bone cancer	0.000312	0.00446	CcSEcCtD
Bezafibrate—Anaemia—Methotrexate—bone cancer	0.000308	0.00441	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—bone cancer	0.000307	0.0044	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—bone cancer	0.000304	0.00232	CbGpPWpGaD
Bezafibrate—Muscle spasms—Epirubicin—bone cancer	0.0003	0.00429	CcSEcCtD
Bezafibrate—Nausea—Cisplatin—bone cancer	0.000294	0.00421	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—bone cancer	0.000293	0.00419	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—bone cancer	0.000288	0.00413	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—bone cancer	0.000288	0.00412	CcSEcCtD
Bezafibrate—PPARA—Metabolism—NT5C3A—bone cancer	0.000287	0.00219	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NR1I2—bone cancer	0.000285	0.00218	CbGpPWpGaD
Bezafibrate—Flatulence—Doxorubicin—bone cancer	0.000284	0.00407	CcSEcCtD
Bezafibrate—Myalgia—Methotrexate—bone cancer	0.000284	0.00406	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.00028	0.00214	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—RB1—bone cancer	0.000279	0.00214	CbGpPWpGaD
Bezafibrate—Muscle spasms—Doxorubicin—bone cancer	0.000277	0.00397	CcSEcCtD
Bezafibrate—Infection—Methotrexate—bone cancer	0.00027	0.00387	CcSEcCtD
Bezafibrate—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.00027	0.00206	CbGpPWpGaD
Bezafibrate—Anaemia—Doxorubicin—bone cancer	0.000267	0.00382	CcSEcCtD
Bezafibrate—Thrombocytopenia—Methotrexate—bone cancer	0.000266	0.00381	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—bone cancer	0.000265	0.0038	CcSEcCtD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00026	0.00199	CbGpPWpGaD
Bezafibrate—Infection—Epirubicin—bone cancer	0.000253	0.00362	CcSEcCtD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00025	0.00191	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Epirubicin—bone cancer	0.000249	0.00356	CcSEcCtD
Bezafibrate—PPARG—Metabolism—NDUFA12—bone cancer	0.000248	0.0019	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000248	0.00354	CcSEcCtD
Bezafibrate—Insomnia—Methotrexate—bone cancer	0.000246	0.00352	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—bone cancer	0.000245	0.00351	CcSEcCtD
Bezafibrate—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000243	0.00186	CbGpPWpGaD
Bezafibrate—Dyspepsia—Methotrexate—bone cancer	0.000239	0.00342	CcSEcCtD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000234	0.00179	CbGpPWpGaD
Bezafibrate—Infection—Doxorubicin—bone cancer	0.000234	0.00335	CcSEcCtD
Bezafibrate—Pain—Methotrexate—bone cancer	0.000232	0.00333	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000232	0.00332	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—bone cancer	0.00023	0.0033	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—bone cancer	0.00023	0.00329	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—CDK4—bone cancer	0.000227	0.00173	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—FUS—bone cancer	0.000225	0.00172	CbGpPWpGaD
Bezafibrate—Dyspepsia—Epirubicin—bone cancer	0.000224	0.0032	CcSEcCtD
Bezafibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000223	0.00171	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Methotrexate—bone cancer	0.000222	0.00318	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.00022	0.00168	CbGpPWpGaD
Bezafibrate—Pain—Epirubicin—bone cancer	0.000217	0.00311	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—bone cancer	0.000217	0.00311	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—NR1I2—bone cancer	0.000217	0.00166	CbGpPWpGaD
Bezafibrate—Urticaria—Methotrexate—bone cancer	0.000216	0.00309	CcSEcCtD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000216	0.00165	CbGpPWpGaD
Bezafibrate—Abdominal pain—Methotrexate—bone cancer	0.000215	0.00308	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000214	0.00307	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—bone cancer	0.000213	0.00305	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—EIF2S1—bone cancer	0.000211	0.00161	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Epirubicin—bone cancer	0.000208	0.00298	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—bone cancer	0.000207	0.00297	CcSEcCtD
Bezafibrate—PPARG—Metabolism—NT5C3A—bone cancer	0.000206	0.00157	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000204	0.00156	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—JUN—bone cancer	0.000204	0.00156	CbGpPWpGaD
Bezafibrate—Urticaria—Epirubicin—bone cancer	0.000202	0.00289	CcSEcCtD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000202	0.00154	CbGpPWpGaD
Bezafibrate—Constipation—Doxorubicin—bone cancer	0.000201	0.00288	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—bone cancer	0.000201	0.00288	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—bone cancer	0.000201	0.00288	CcSEcCtD
Bezafibrate—Hypersensitivity—Methotrexate—bone cancer	0.0002	0.00287	CcSEcCtD
Bezafibrate—SLCO1B1—Metabolism—NDUFA12—bone cancer	0.000195	0.00149	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Doxorubicin—bone cancer	0.000192	0.00275	CcSEcCtD
Bezafibrate—Pruritus—Methotrexate—bone cancer	0.000192	0.00275	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—bone cancer	0.000187	0.00268	CcSEcCtD
Bezafibrate—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000187	0.00143	CbGpPWpGaD
Bezafibrate—Urticaria—Doxorubicin—bone cancer	0.000187	0.00268	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—bone cancer	0.000186	0.00266	CcSEcCtD
Bezafibrate—Diarrhoea—Methotrexate—bone cancer	0.000186	0.00266	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000185	0.00141	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000185	0.00141	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000184	0.00141	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000184	0.00141	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—EZH2—bone cancer	0.000183	0.0014	CbGpPWpGaD
Bezafibrate—Pruritus—Epirubicin—bone cancer	0.00018	0.00258	CcSEcCtD
Bezafibrate—Dizziness—Methotrexate—bone cancer	0.00018	0.00257	CcSEcCtD
Bezafibrate—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000175	0.00134	CbGpPWpGaD
Bezafibrate—Diarrhoea—Epirubicin—bone cancer	0.000174	0.00249	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—bone cancer	0.000173	0.00248	CcSEcCtD
Bezafibrate—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000172	0.00132	CbGpPWpGaD
Bezafibrate—Rash—Methotrexate—bone cancer	0.000171	0.00245	CcSEcCtD
Bezafibrate—Dermatitis—Methotrexate—bone cancer	0.000171	0.00245	CcSEcCtD
Bezafibrate—Headache—Methotrexate—bone cancer	0.00017	0.00244	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—bone cancer	0.000168	0.00241	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—bone cancer	0.000166	0.00238	CcSEcCtD
Bezafibrate—PPARD—Metabolism—ENO2—bone cancer	0.000165	0.00126	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NT5C3A—bone cancer	0.000162	0.00124	CbGpPWpGaD
Bezafibrate—Nausea—Methotrexate—bone cancer	0.000161	0.00231	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—bone cancer	0.000161	0.0023	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—EIF2S1—bone cancer	0.000161	0.00123	CbGpPWpGaD
Bezafibrate—Rash—Epirubicin—bone cancer	0.00016	0.0023	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—bone cancer	0.00016	0.00229	CcSEcCtD
Bezafibrate—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.00016	0.00123	CbGpPWpGaD
Bezafibrate—Headache—Epirubicin—bone cancer	0.000159	0.00228	CcSEcCtD
Bezafibrate—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000158	0.00121	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NR1I2—bone cancer	0.000156	0.00119	CbGpPWpGaD
Bezafibrate—Dizziness—Doxorubicin—bone cancer	0.000156	0.00223	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—MET—bone cancer	0.000154	0.00118	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CDK4—bone cancer	0.000154	0.00118	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—DHFR—bone cancer	0.000153	0.00117	CbGpPWpGaD
Bezafibrate—Nausea—Epirubicin—bone cancer	0.000151	0.00216	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—bone cancer	0.000148	0.00212	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—bone cancer	0.000148	0.00212	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—bone cancer	0.000147	0.00211	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—JUN—bone cancer	0.000146	0.00112	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GNA11—bone cancer	0.000143	0.00109	CbGpPWpGaD
Bezafibrate—Nausea—Doxorubicin—bone cancer	0.00014	0.002	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—EZH2—bone cancer	0.00014	0.00107	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ENO2—bone cancer	0.000137	0.00105	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—bone cancer	0.000134	0.00103	CbGpPWpGaD
Bezafibrate—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000133	0.00102	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP3A4—bone cancer	0.00013	0.000992	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000129	0.000987	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP2—bone cancer	0.000128	0.000983	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—DHFR—bone cancer	0.000127	0.000975	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ENO2—bone cancer	0.000126	0.000961	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NDUFA12—bone cancer	0.000122	0.000937	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GNA11—bone cancer	0.000119	0.000911	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—DHFR—bone cancer	0.000117	0.000892	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EIF2S1—bone cancer	0.000115	0.000881	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NDUFA12—bone cancer	0.000112	0.000859	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTP1—bone cancer	0.000111	0.000848	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MET—bone cancer	0.00011	0.000844	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CDK4—bone cancer	0.00011	0.000844	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GNA11—bone cancer	0.000109	0.000834	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP3A4—bone cancer	0.000108	0.000826	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000107	0.000822	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NT5C3A—bone cancer	0.000101	0.000776	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EZH2—bone cancer	0.0001	0.000765	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP3A4—bone cancer	9.88e-05	0.000756	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.83e-05	0.000752	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP9—bone cancer	9.65e-05	0.000739	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—bone cancer	9.64e-05	0.000737	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NT5C3A—bone cancer	9.3e-05	0.000712	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTP1—bone cancer	9.24e-05	0.000707	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP2—bone cancer	9.21e-05	0.000704	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ENO2—bone cancer	9.01e-05	0.000689	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTP1—bone cancer	8.6e-05	0.000658	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	8.48e-05	0.000649	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTP1—bone cancer	8.45e-05	0.000646	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—DHFR—bone cancer	8.36e-05	0.000639	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GNA11—bone cancer	7.81e-05	0.000597	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—bone cancer	7.8e-05	0.000597	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ENO2—bone cancer	7.09e-05	0.000543	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP3A4—bone cancer	7.08e-05	0.000542	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.04e-05	0.000539	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—bone cancer	6.92e-05	0.000529	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—DHFR—bone cancer	6.58e-05	0.000503	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GNA11—bone cancer	6.15e-05	0.00047	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—bone cancer	6.06e-05	0.000463	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NDUFA12—bone cancer	6.03e-05	0.000461	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—bone cancer	5.75e-05	0.00044	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—bone cancer	5.59e-05	0.000428	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP3A4—bone cancer	5.58e-05	0.000426	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.55e-05	0.000424	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NT5C3A—bone cancer	4.99e-05	0.000382	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—bone cancer	4.79e-05	0.000366	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—bone cancer	4.77e-05	0.000365	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO2—bone cancer	4.45e-05	0.00034	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—bone cancer	4.38e-05	0.000335	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—DHFR—bone cancer	4.12e-05	0.000315	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO2—bone cancer	4.08e-05	0.000312	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNA11—bone cancer	3.85e-05	0.000295	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—DHFR—bone cancer	3.78e-05	0.000289	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNA11—bone cancer	3.53e-05	0.00027	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP3A4—bone cancer	3.49e-05	0.000267	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.48e-05	0.000266	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP3A4—bone cancer	3.2e-05	0.000245	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.19e-05	0.000244	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—bone cancer	3.14e-05	0.00024	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—bone cancer	2.99e-05	0.000229	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—bone cancer	2.74e-05	0.00021	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—bone cancer	2.47e-05	0.000189	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO2—bone cancer	2.19e-05	0.000167	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DHFR—bone cancer	2.03e-05	0.000155	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNA11—bone cancer	1.9e-05	0.000145	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—bone cancer	1.55e-05	0.000118	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—bone cancer	1.47e-05	0.000112	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—bone cancer	1.42e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—bone cancer	7.62e-06	5.83e-05	CbGpPWpGaD
